Detalhe da pesquisa
1.
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica
; 108(10): 2774-2782, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078253
2.
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
Hematol Oncol
; 40(5): 976-986, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789106
3.
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
Eur Radiol
; 31(5): 2944-2955, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155106
4.
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Blood
; 128(6): 774-82, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121472
5.
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study.
Blood Adv
; 6(16): 4807-4815, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772168
6.
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
Neurology
; 94(10): e1027-e1039, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907289
7.
Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Cancer Genet Cytogenet
; 140(2): 118-23, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12645649
8.
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.
Vaccine
; 32(5): 585-91, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24333120
9.
Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.
J Clin Oncol
; 32(5): 424-30, 2014 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24323036
10.
Reply to J. Richter et al.
J Clin Oncol
; 32(25): 2823-5, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25071119